Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1677-2011

OSTEOMATRIX bone graft substitute. OMG10. Osteomatrix is provided sterile for single patient use

Biostructures, LLC / initiated 2011-01-31 / Terminated / root cause: labeling and UDI

Biostructures, LLC began a recall of OSTEOMATRIX bone graft substitute. OMG10. Osteomatrix is provided sterile for single patient use on . The reason FDA records is "The OsteoMatrix Synthetic Bone Graft Composite Instructions for Use document, P4G10A/Rev. 01 had language that was not consistent with the cleared indications". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1677-2011
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Biostructures, LLC
Product
OSTEOMATRIX bone graft substitute. OMG10. Osteomatrix is provided sterile for single patient use.
Product code
MQV Filler, Bone Void, Calcium Compound
Reason for recall
The OsteoMatrix Synthetic Bone Graft Composite Instructions for Use document, P4G10A/Rev. 01 had language that was not consistent with the cleared indications.
Root cause tag
labeling and UDI
FDA root cause
Other
Action
An email was sent on 06/15/2010 to the firm's distributors that had products with lot #0809D110 or lot #0307I208 in their possesion. The email was in regards to the distributors' OMG10 granule inventory. The distributors need to return all the recalled granule inventory to be swapped out for new inventory.
Quantity in commerce
248 units
Distribution
Products were distributed to 6 consignees that were located in Michigan, Ohio, Maryland, California, Texas, and Utah.
Product codes and lots
OMG10/Lot # 0809D110 OMG10/Lot # 0307I208